Profiles

Mohammed Salahudeen

UTAS Home Dr Mohammed Salahudeen

Mohammed Salahudeen

Lecturer in Clinical Pharmacy

Room 4014 , Pharmacy

+61 3 6226 1837 (phone)

Mohammed.Salahudeen@utas.edu.au

Dr Mohammed Salahudeen is a Lecturer in Clinical Pharmacy at the Division of Pharmacy, School of Medicine. Mohammed trained as a clinical pharmacist with extensive expertise in the areas of pharmacotherapy and quality use of medicine. His research interests are in Clinical Pharmacy towards Evidence Based Medicine, Geriatric Pharmacoepidemiology and Quality Use of Medicines.

Biography

Prior to joining the University of Tasmania, Dr Mohammed worked as a Postdoctoral Research Fellow in School of Pharmacy, University of Otago (NZ), where he was examining the risks associated with polypharmacy among older New Zealanders using the interRAI home care data.

Dr Salahudeen completed his PhD in Clinical Pharmacy from the University of Otago, New Zealand and holds PharmD, MBA and BPharm degrees from other international universities. He has completed one year Clinical Pharmacy Internship as a part of PharmD program. After completion of PhD, Mohammed was awarded a prestigious Career Development Fellowship from the Division of Health Sciences, University of Otago to undertake Postdoctoral research in Clinical Pharmacy.

During his time as a Lecturer at Gulf Medical University, Mohammed took initiative to start-up a Pharmaceutical Care Clinic within the university hospital. He also worked as a Pharmacy Coordinator in Gulf Medical College chain of Hospitals (UAE), where he exhibited skills to maintain day-to-day pharmacy activities, monitor and prioritise drug inventory and over-the-counter stocks. Throughout his career, Dr Mohammed has worked on several research projects and has co-authored a number of peer-reviewed publications within the scope of Clinical Pharmacy.

Career summary

Qualifications

Degree

Thesis title

University

Country

Date

PhD

Examination and estimation of anticholinergic burden

University of Otago

New Zealand

2016

MBA in Hospital Management

 

Bharathiar University

India

2012

PharmD

Prevalence and predictors of polypharmacy in a tertiary hospital setting

JSS University

India

2011

BPharm

Formulation and evaluation of ciprofloxacin hydrochloride ocular inserts

The Tamil Nadu Dr. M.G.R. Medical University

India

2008

Memberships

Professional practice

  • Australasian Pharmaceutical Science Association (APSA)
  • International Society for Pharmacoepidemiology (ISPE)

Teaching

Teaching responsibility

View more on Dr Mohammed Salahudeen in WARP

Expertise

  • Aged Health Care (111702)
  • Clinical Pharmacology and Therapeutics (111502)
  • Clinical Pharmacy and Pharmacy Practice (111503)
  • Cardiology (incl. Cardiovascular Diseases) (110201)
  • Epidemiology (111706)
  • Geriatrics and Gerontology (110308)
  • Infectious Diseases (110309)
  • Mental Health (111714)
  • Pharmacology and Pharmaceutical Sciences (111599)
  • Preventive Medicine (111716)
  • Psychiatry (incl. Psychotherapy) (110319)
  • Public Health and Health Services (111799)
  • Health Policy (160508)

Research Themes

Mohammed’s research aligns to the University’s research theme of Better Health. His research interests are in Geriatric Pharmacoepidemiology, Evidence Based Medicine and Quality use of Medicines. Mohammed has a special research interest in issues allied to the anticholinergic science and has published several papers on this topic.

Awards

  • Postdoctoral Fellowship – Awarded from the Division of Health Sciences ($151,792), University of Otago, New Zealand.
  • Best Postgraduate Research Paper of the Year 2015 ($500) - Awarded from the School of Pharmacy, University of Otago, New Zealand.
  • Doctoral Scholarship for PhD from the University of Otago, New Zealand

Fields of Research

  • Clinical pharmacy and pharmacy practice (321403)
  • Clinical pharmacology and therapeutics (321402)
  • Geriatrics and gerontology (320210)
  • Aged health care (420301)
  • Sports medicine (320225)
  • Health promotion (420603)
  • Community child health (420601)
  • Intensive care (320212)
  • Infectious diseases (320211)
  • Continuing and community education (390301)
  • Orthodontics and dentofacial orthopaedics (320308)
  • Toxicology (incl. clinical toxicology) (321407)
  • Environment and resource economics (380105)
  • Social psychology (520505)
  • Acute care (420501)

Research Objectives

  • Evaluation of health outcomes (200202)
  • Health education and promotion (200203)
  • Evaluation of health and support services (200299)
  • Health related to ageing (200502)
  • Efficacy of medications (200102)
  • Clinical health (200199)
  • Diagnosis of human diseases and conditions (200101)
  • Mental health (200409)
  • Provision of health and support services (200399)
  • Primary care (200310)
  • Higher education (160102)
  • Health status (incl. wellbeing) (200407)
  • Preventive medicine (200412)
  • Prevention of human diseases and conditions (200104)
  • Other health (209999)
  • Neonatal and child health (200506)
  • Specific population health (excl. Indigenous health) (200599)
  • Behaviour and health (200401)
  • Public health (excl. specific population health) (200499)
  • Men's health (200504)

Publications

Total publications

56

Journal Article

(40 outputs)
YearCitationAltmetrics
2022Ali S, Curtain C, Bereznicki LRE, Salahudeen MS, 'Actual drug-related harms in residential aged care facilities: a narrative review', Expert Opinion on Drug Safety, 21, (8) pp. 1047-1060. ISSN 1474-0338 (2022) [Refereed Article]

DOI: 10.1080/14740338.2022.2084071 [eCite] [Details]

Co-authors: Ali S; Curtain C; Bereznicki LRE

Tweet

2022Atey TM, Peterson GM, Salahudeen MS, Bereznicki LR, Wimmer BC, 'Impact of pharmacist interventions provided in the emergency department on quality use of medicines: a systematic review and meta-analysis', Emergency Medicine Journal pp. 1-8. ISSN 1472-0205 (2022) [Refereed Article]

DOI: 10.1136/emermed-2021-211660 [eCite] [Details]

Co-authors: Peterson GM; Bereznicki LR; Wimmer BC

Tweet

2022Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population-based cohort study', Journal of the American Heart Association, 11, (7) Article e023098. ISSN 2047-9980 (2022) [Refereed Article]

DOI: 10.1161/JAHA.121.023098 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Garrahy E; Bindoff I; Peterson GM

Tweet

2022Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants', Expert Review of Clinical Pharmacology, 15, (3) Article 359-364. ISSN 1751-2433 (2022) [Refereed Article]

DOI: 10.1080/17512433.2022.2070151 [eCite] [Details]

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Bindoff I; Peterson GM

Tweet

2022Bezabhe WM, Radford J, Wimmer BC, Salahudeen MS, Bindoff I, et al., 'Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapy', Expert Review of Clinical Pharmacology, 15, (8) pp. 1003-1010. ISSN 1751-2433 (2022) [Refereed Article]

DOI: 10.1080/17512433.2022.2103540 [eCite] [Details]

Co-authors: Bezabhe WM; Radford J; Wimmer BC; Bindoff I; Ling T; Peterson GM

Tweet

2022Salahudeen MS, Alfahmi A, Farooq A, Akhtar M, Ajaz S, et al., 'Effectiveness of interventions to improve the anticholinergic prescribing practice in older adults: a systematic review', Journal of Clinical Medicine, 11, (3) Article 714. ISSN 2077-0383 (2022) [Refereed Article]

DOI: 10.3390/jcm11030714 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Alfahmi A; Ali S

Tweet

2022Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS, 'Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia', Therapeutic Advances in Drug Safety, 13 pp. 1-9. ISSN 2042-0994 (2022) [Refereed Article]

DOI: 10.1177/20420986221080796 [eCite] [Details]

Co-authors: Zaidi AS; Peterson GM; Bereznicki LRE; Curtain CM

Tweet

2021Ali S, Salahudeen MS, Bereznicki LRE, Curtain CM, 'Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: a systematic review', British Journal of Clinical Pharmacology ISSN 0306-5251 (2021) [Refereed Article]

DOI: 10.1111/bcp.14824 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Ali S; Bereznicki LRE; Curtain CM

Tweet

2021Bezabhe WM, Bereznicki LR, Radford J, Salahudeen MS, Garrahy E, et al., 'Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation', Internal Medicine Journal, 51, (10) pp. 1732-1735. ISSN 1444-0903 (2021) [Refereed Article]

DOI: 10.1111/imj.15514 [eCite] [Details]

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Garrahy E; Wimmer BC; Bindoff I; Peterson GM

Tweet

2021Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Curtain C, et al., 'Ten-Year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation', Frontiers in Pharmacology, 12 Article 586370. ISSN 1663-9812 (2021) [Refereed Article]

DOI: 10.3389/fphar.2021.586370 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Curtain C; Peterson GM

Tweet

2021Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: a ten-year follow-up', European Journal of Clinical Investigation Article e13489. ISSN 0014-2972 (2021) [Refereed Article]

DOI: 10.1111/eci.13489 [eCite] [Details]

Citations: Scopus - 6Web of Science - 8

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Garrahy E; Bindoff I; Peterson GM

Tweet

2021Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Eight-year trends in direct-acting oral anticoagulant dosing, based on age and kidney function, in patients with atrial fibrillation', Journal of Patient Safety pp. 1-5. ISSN 1549-8417 (2021) [Refereed Article]

DOI: 10.1097/PTS.0000000000000924 [eCite] [Details]

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Peterson GM

Tweet

2020Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Curtain C, et al., 'Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation', European Journal of Clinical Investigation, 51, (5) Article e13457. ISSN 0014-2972 (2020) [Refereed Article]

DOI: 10.1111/eci.13457 [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Curtain C; Peterson GM

Tweet

2020Bezabhe WM, Bereznicki LR, Radford J, Wimmer BC, Salahudeen MS, et al., 'Five-year trends in potential drug interactions with direct-acting oral anticoagulants in patients with atrial fibrillation: an Australian-wide study', Journal of Clinical Medicine, 9, (11) Article 3568. ISSN 2077-0383 (2020) [Refereed Article]

DOI: 10.3390/jcm9113568 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Bindoff I; Garrahy E; Peterson GM

Tweet

2020Salahudeen MS, Wright CM, Peterson GM, 'Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review', Therapeutic Advances in Drug Safety, 11 pp. 71-93. ISSN 2042-0986 (2020) [Refereed Article]

DOI: 10.1177/2042098620937899 [eCite] [Details]

Citations: Scopus - 13Web of Science - 16

Co-authors: Wright CM; Peterson GM

Tweet

2020Yee KC, De Marco M, Salahudeen MS, Peterson GM, Thomas J, et al., 'Pharmacists as a Source of Advice on Medication Use for Athletes', Pharmacy, 8, (1) Article 10. ISSN 2226-4787 (2020) [Refereed Article]

DOI: 10.3390/pharmacy8010010 [eCite] [Details]

Citations: Web of Science - 4

Co-authors: Peterson GM

Tweet

2020Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS, 'Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis', The Annals of Pharmacotherapy, 55, (4) pp. 530-542. ISSN 1060-0280 (2020) [Refereed Article]

DOI: 10.1177/1060028020949125 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Co-authors: Zaidi AS; Peterson GM; Bereznicki LRE; Curtain CM

Tweet

2019Ali S, Peterson GM, Bereznicki L, Salahudeen MS, 'Association between anticholinergic drug burden and mortality in older people: a systematic review', European Journal of Clinical Pharmacology, 76, (3) pp. 319-335. ISSN 0031-6970 (2019) [Refereed Article]

DOI: 10.1007/s00228-019-02795-x [eCite] [Details]

Citations: Scopus - 12Web of Science - 10

Co-authors: Peterson GM; Bereznicki L

Tweet

2019Bongers K, Salahudeen MS, Peterson GM, 'Drug-associated non-pyrogenic hyperthermia: a narrative review', European Journal of Clinical Pharmacology ISSN 0031-6970 (2019) [Refereed Article]

DOI: 10.1007/s00228-019-02763-5 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: Bongers K; Peterson GM

Tweet

2019Bongers KS, Salahudeen MS, Peterson GM, 'Drug-associated hyperthermia: A longitudinal analysis of hospital presentations', Journal of Clinical Pharmacy and Therapeutics pp. 1-11. ISSN 0269-4727 (2019) [Refereed Article]

DOI: 10.1111/jcpt.13090 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Bongers KS; Peterson GM

Tweet

2019Salahudeen MS, 'A review of current evidence allied to step-up and top-down medication therapy in inflammatory bowel disease', Drugs of Today, 55, (6) pp. 385-405. ISSN 1699-3993 (2019) [Refereed Article]

DOI: 10.1358/dot.2019.55.6.2969816 [eCite] [Details]

Citations: Scopus - 4Web of Science - 2

Tweet

2018Salahudeen MS, 'Deprescribing medications in older people: a narrative review', Drugs of Today, 54, (8) pp. 489-498. ISSN 1699-3993 (2018) [Refereed Article]

DOI: 10.1358/dot.2018.54.8.2856495 [eCite] [Details]

Citations: Scopus - 9Web of Science - 7

Tweet

2018Salahudeen MS, Nishtala PS, 'A Systematic Review Evaluating the Use of the interRAI Home Care Instrument in Research for Older People', Clinical gerontologist pp. 1-22. ISSN 0731-7115 (2018) [Refereed Article]

DOI: 10.1080/07317115.2018.1447525 [eCite] [Details]

Citations: Scopus - 12Web of Science - 14

Tweet

2018Sundaran S, Udayan A, Hareendranath K, Eliyas B, Ganesan B, et al., 'Study on the classification, causality, preventability and severity of adverse drug reaction using spontaneous reporting system in hospitalized patients', Pharmacy, 6, (4) Article 108. ISSN 2226-4787 (2018) [Refereed Article]

DOI: 10.3390/pharmacy6040108 [eCite] [Details]

Citations: Web of Science - 14

Tweet

2017Nishtala P, Ndukwe H, Chyou TY, Salahudeen M, Narayan S, 'An overview of pharmacoepidemiology in New Zealand: medical databases, registries and research achievements', The New Zealand medical journal, 130, (1449) pp. 52-61. ISSN 0028-8446 (2017) [Refereed Article]

PMID: 28178730 [eCite] [Details]

Citations: Web of Science - 7

Tweet

2017Salahudeen MS, Nishtala PS, 'An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice', Saudi pharmaceutical journal, 25, (2) pp. 165-175. ISSN 1319-0164 (2017) [Refereed Article]

DOI: 10.1016/j.jsps.2016.07.002 [eCite] [Details]

Citations: Scopus - 51Web of Science - 42

Tweet

2016Nishtala PS, Castelino RL, Peterson GM, Hannan PJ, Salahudeen MS, 'Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk', Journal of Clinical Pharmacy and Therapeutics, 41, (3) pp. 279-284. ISSN 0269-4727 (2016) [Refereed Article]

DOI: 10.1111/jcpt.12385 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Castelino RL; Peterson GM

Tweet

2016Nishtala PS, Salahudeen MS, 'Cognitive adverse effects and brain deterioration associated with use of anticholinergic activity medicines in older adults', Evidence - Based Medicine (English Edition): for primary care and internal medicine ISSN 1356-5524 (2016) [Contribution to Refereed Journal]

DOI: 10.1136/ebmed-2016-110555 [eCite] [Details]

Citations: Scopus - 1

Tweet

2016Nishtala PS, Salahudeen MS, 'Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand', Therapeutic advances in drug safety, 7, (5) pp. 184-194. ISSN 2042-0986 (2016) [Refereed Article]

DOI: 10.1177/2042098616660948 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Tweet

2016Nishtala PS, Salahudeen MS, Hilmer SN, 'Anticholinergics: theoretical and clinical overview', Expert opinion on drug safety, 15, (6) pp. 753-768. ISSN 1474-0338 (2016) [Refereed Article]

DOI: 10.1517/14740338.2016.1165664 [eCite] [Details]

Citations: Scopus - 73Web of Science - 77

Tweet

2016Salahudeen M, Nishtala PS, 'Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research', Drugs and Aging, 33, (5) pp. 305-313. ISSN 1170-229X (2016) [Refereed Article]

DOI: 10.1007/s40266-016-0362-5 [eCite] [Details]

Citations: Scopus - 17Web of Science - 16

Tweet

2016Salahudeen MS, Chyou T-Y, Nishtala PS, 'Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature', PloS one, 11, (3) ISSN 1932-6203 (2016) [Refereed Article]

DOI: 10.1371/journal.pone.0151084 [eCite] [Details]

Citations: Scopus - 27Web of Science - 27

Tweet

2016Salahudeen MS, Nishtala PS, Duffull SB, 'The Influence of Patient Characteristics on Anticholinergic Events in Older People', Dementia and geriatric cognitive disorders extra, 5, (3) pp. 530-541. ISSN 1664-5464 (2016) [Refereed Article]

DOI: 10.1159/000441718 [eCite] [Details]

Citations: Scopus - 15

Tweet

2015Nishtala PS, Salahudeen MS, 'Temporal trends in Polypharmacy and Hyperpolypharmacy in older New Zealanders over a 9-Year period: 2005-2013', Gerontology, 61, (3) pp. 195-202. ISSN 0304-324X (2015) [Refereed Article]

DOI: 10.1159/000368191 [eCite] [Details]

Citations: Scopus - 63Web of Science - 63

Tweet

2015Salahudeen MS, Duffull SB, Nishtala PS, 'Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review', BMC geriatrics, 15 pp. 1-14. ISSN 1471-2318 (2015) [Refereed Article]

DOI: 10.1186/s12877-015-0029-9 [eCite] [Details]

Citations: Scopus - 242Web of Science - 237

Tweet

2015Salahudeen MS, Hilmer SN, Nishtala PS, 'Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people', Journal of the American Geriatrics Society, 63, (1) pp. 85-90. ISSN 0002-8614 (2015) [Refereed Article]

DOI: 10.1111/jgs.13206 [eCite] [Details]

Citations: Scopus - 111Web of Science - 110

Tweet

2015Salahudeen MS, Nishtala PS, 'Credentials for a PharmD graduate: The voyage never ends', SAGE open medicine pp. 1-5. ISSN 2050-3121 (2015) [Refereed Article]

DOI: 10.1177/2050312115584228 [eCite] [Details]

Citations: Web of Science - 3

Tweet

2014Salahudeen MS, Duffull B, Nishtala PS, 'Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review', Drugs & Aging, 31, (3) pp. 185-192. ISSN 1170-229X (2014) [Refereed Article]

DOI: 10.1007/s40266-014-0158-4 [eCite] [Details]

Citations: Scopus - 31Web of Science - 29

Tweet

2013Kulkarni V, Bora SS, Sirisha S, Saji M, Sundaran S, 'A study on drug-drug interactions through prescription analysis in a South Indian teaching hospital', Therapeutic advances in drug safety, 4, (4) pp. 141-146. ISSN 2042-0986 (2013) [Refereed Article]

DOI: 10.1177/2042098613490009 [eCite] [Details]

Citations: Scopus - 15Web of Science - 13

Tweet

2013Salahudeen M, Koshy AM, Sen S, 'A study of the factors affecting time to onset of lactogenesis-II after parturition', Journal of Pharmacy Research, 6, (1) pp. 68-72. ISSN 0974-6943 (2013) [Refereed Article]

DOI: 10.1016/j.jopr.2012.11.015 [eCite] [Details]

Tweet

Conference Publication

(15 outputs)
YearCitationAltmetrics
2022Gharib A, Bindoff I, Peterson G, Salahudeen M, 'Barriers and facilitators impacting the uptake of computer-based simulation in pharmacy education', openjournals.library.sydney.edu.au, 15-17 February 2022, Online, pp. 1. (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Gharib A; Bindoff I; Peterson G

Tweet

2022Gulal O, Salahudeen M, Nash R, Curtain C, 'Australian pharmacists' opinions of their CPD requirements', OnShore Refresher Conference, 4th- 10th May 2022, Darwin, pp. 1. (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Nash R; Curtain C

Tweet

2021Ali S, Salahudeen MS, Bereznicki LRE, Curtain CM, 'Pharmacist's interventions to reduce the occurrence of drug-related harms in older residents: a systematic review', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, virtual, pp. 29. (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Ali S; Bereznicki LRE; Curtain CM

2021Atey TM, Peterson GM, Salahudeen MS, Bereznicki LR, Wimmer B, 'Impact of partnered pharmacist medication charting in the Royal Hobart Hospital emergency department on medication discrepancies and errors: preliminary results', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, virtual, pp. 36. (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Peterson GM; Bereznicki LR; Wimmer B

2021Gharib A, Bindoff I, Peterson G, Salahudeen M, 'An overview of available computer-based simulation tools in pharmacy practice education', APSA 2021 Annual Conference Book of Oral Abstracts, 06-08 December, virtual, pp. 39. (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Gharib A; Bindoff I; Peterson G

2021Zaidi AS, Peterson GM, Bereznicki LRE, Curtain CM, Salahudeen MS, 'Adverse drug reaction-related hospitalisations among people with dementia', APSA-ASCEPT 2022 Joint Conference Book of Abstracts, 29 November - 02 December 2022, Perth, pp. 312. (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Zaidi AS; Peterson GM; Bereznicki LRE; Curtain CM

Tweet

2019Ali S, Peterson GM, Bereznicki LRE, Salahudeen MS, 'Association between anticholinergic drug burden and mortality in older people: an evidence-based approach', 22-26 September 2019, Abu Dhabi, United Arab Emirates (2019) [Conference Edited]

[eCite] [Details]

Co-authors: Peterson GM; Bereznicki LRE

2017Salahudeen MS, 'Invited Chair', BIT's 5th Annual World Congress of Geriatrics and Gerontology -2017, 4-6 December 2017, Fukuoka, Japan (2017) [Chair International Conference]

[eCite] [Details]

2017Salahudeen MS, 'Geriatric Safe Medicines and Medication Management: Application of the interRAI home care assessments in Geriatric Research and Medication Management', BIT's 5th Annual World Congress of Geriatrics and Gerontology, 3-6 December 2017, Fukuoka, Japan (2017) [Chair International Conference]

[eCite] [Details]

2016Salahudeen MS, Chyou T-Y, Nishtala PS, 'A systematic review and meta-analysis on serum anticholinergic activity and adverse outcomes in older people', Research in Social and Administrative Pharmacy, pp. e35-e36. ISSN 1551-7411 (2016) [Conference Extract]

DOI: 10.1016/j.sapharm.2016.05.086 [eCite] [Details]

Tweet

2015Salahudeen MS, Chyou T-Y, Nishtala PS, 'A systematic review and meta-analysis on serum anticholinergic activity and adverse outcomes in older people', 29 Nov - 2 Dec 2015, Hobart, Tasmania (2015) [Conference Edited]

[eCite] [Details]

2015Salahudeen MS, Nishtala PS, Duffull SB, 'Model-based estimation of anticholinergic burden', 29 Nov - 2 Dec 2015, Melbourne, Australia (2015) [Conference Edited]

[eCite] [Details]

Tweet

2014Prasad N, Salahudeen MS, Narayan S, 'A comparison of anticholinergic risk scales and associations to adverse health outcomes in older people', 13-16 April 2014, Melbourne, Australia (2014) [Conference Edited]

[eCite] [Details]

Tweet

2014Salahudeen MS, Nishtala PS, Duffull SB, 'Estimating the relative potencies of an anticholinergic medicine: A methodological view point', PAGANZ conference 2014, 29-31 January 2014, Dunedin , New Zealand (2014) [Conference Extract]

[eCite] [Details]

Tweet

2013Salahudeen MS, Duffull SB, Nishtala P, 'Impact of anticholinergic discontinuation on cognitive outcomes in older people', 2013 Australasian Pharmaceutical Science Association (APSA), 8-11 December 2013, Dunedin , New Zealand (2013) [Conference Extract]

[eCite] [Details]

Tweet

Thesis

(1 outputs)
YearCitationAltmetrics
2016Salahudeen MS, 'Examination and Estimation of Anticholinergic Burden' (2016) [PhD]

[eCite] [Details]

Grants & Funding

Funding Summary

Number of grants

2

Total funding

$19,981

Projects

Intervention to lessen anticholinergic drug burden in hospitalised older adults (2022)$9,996
Description
Drugs with anticholinergic properties carry significant risks in older people, including extended hospital admissions, falls, dementia and increased mortality. However, the pattern of anticholinergic drug prescribing in Tasmania is not yet known. This study will investigate the effectiveness of an educational intervention to improve prescribing of anticholinergic-type drugs.
Funding
Royal Hobart Hospital Research Foundation ($9,996)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Salahudeen MS; Peterson GM; Adamczewski B; Hoyle D; McKenzie D; Bezabhe W
Year
2022
Adverse drug reaction-related hospital admission in elderly Australians with dementia (2020)$9,985
Description
Dementia is a significant risk factor for serious side effects of medicines or adverse drug reactions (ADRs). This prospective study will investigate and identify the prevalence and risk factors for ADR-related hospital admissions in elderly patients with dementia or cognitive impairment.
Funding
Royal Hobart Hospital Research Foundation ($9,985)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Parameswaran Nair N; Bereznicki LRE; Adamczewski B; Salahudeen MS; Bereznicki BJ
Year
2020

Research Supervision

Current

7

Current

DegreeTitleCommenced
PhDPartnered Pharmacist Medication Charting: Evaluation of a process change2019
PhDTowards Improved Safety and Health Outcomes Associated with Medication Use in People with Dementia2019
PhDAddressing Drug-Related Harms among Older Australians in Residential Aged Care Facilities2020
PhDUnderstanding Barriers and Facilitators Impacting the Integration of Computer-based Simulation in Pharmacy Education2020
PhDDeprescribing Preventative Cardiovascular Medications in Older Australians2021
PhDEvaluation of Medication Use and Management Among Older Patients With Dementia in Australian General Practice2021
PhDEvaluation of Drug-Related Problems and Pharmacotherapy Complexity in Older Adults with Diabetes2021